ArticleMedicine2026
Does adding ultrasound-guided subacromial injection improve clinical outcomes after suprascapular nerve block in chronic subacromial impingement syndrome?: A retrospective cohort study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ultrasound-guided suprascapular nerve block (SSNB) and subacromial injection (SI) are commonly used for chronic subacromial impingement syndrome (SIS), but the additional benefit of combining these interventions remains uncertain. This study evaluated whether adding ultrasound-guided SI to SSNB improves clinical outcomes in patients with chronic MRI-confirmed SIS who had failed conservative treatment. This retrospective cohort study included consecutive patients with chronic SIS treated between December 2021 and January 2025. Patients underwent ultrasound-guided SSNB alone or combined SSNB with SI according to routine clinical practice. SIS was classified by MRI as grade 1 (tendinopathy), grade 2 (partial-thickness rotator cuff tear), or grade 3 (full-thickness rotator cuff tear). The primary outcome was treatment success, defined as a ≥50% reduction in Numerical Rating Scale (NRS) score at 3 months. Secondary outcomes included pain intensity, patient satisfaction, and treatment outcomes according to MRI grade. Sixty-one patients were included (30 SSNB and 31 SSNB + SI). Both treatment groups demonstrated substantial pain reduction during follow-up. Treatment success rates were similar between the SSNB and SSNB + SI groups (86.7% vs 87.1%, P = .999), as were patient satisfaction rates (86.7% vs 87.1%, P = .946). No significant between-group differences were observed in NRS scores at 1 or 3 months. Treatment success was significantly higher in patients with grade 1 SIS than in those with grade 2 SIS (97.4% vs 80.0%, P = .044). All 3 patients with grade 3 SIS experienced treatment failure. Ultrasound-guided SSNB was associated with favorable short-term outcomes in patients with chronic SIS who had failed conservative treatment. Adding ultrasound-guided SI did not provide additional improvement in pain, treatment success, or patient satisfaction over 3 months. Higher treatment success was observed in patients with grade 1 SIS than in those with more advanced disease. Larger prospective randomized studies are needed to confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.